CAS No.104-31-4,Benzonatate Suppliers

Products Categories

Pharmaceutical (39)
Others (25)
Organic Chemicals (17)
Reagent (1)
(1)

Basic Information

Molecular Structure:
CAS No.:	104-31-4
Name:	Benzonatate

Formula:	C₃₀H₅₃NO₁₁
Molecular Weight:	603.75
Synonyms:	Benzoicacid, p-(butylamino)-, 2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethylester (8CI);Benzoic acid, p-(butylamino)-, ester with2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-ol (6CI,7CI);Benzononantin;Benzononatine;Exangit;KM 65;Tesalon;Tessalin;Tessalon;Tessalon-Ciba;Ventussin;Ventussin-Loz;
EINECS:	203-194-7
Density:	1.096 g/cm³
Boiling Point:	649 °C at 760 mmHg
Flash Point:	346.3 °C
Appearance:	pale yellow oily liquid
Hazard Symbols:	Xi
PSA:	121.40000
LogP:	2.90760

Total:74 Page 1 of 2 1 2 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 104-31-4

Specification

The Benzonatate is an organic compound with the formula C₃₀H₅₃NO₁₁. The IUPAC name of this chemical is 2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-(butylamino)benzoate. With the CAS registry number 104-31-4, it is also named as 4-(Butylamino)benzoic Acid 3,6,9,12,15,18,21,24,27-Nonaoxaoctacos-1-yl Ester. The product's categories are Chemical Amines; Amines; Intermediates & Fine Chemicals; Pharmaceuticals. Besides, it is a potent antitussive, which is employed to reduce coughing in various respiratory conditions such as asthma, bronchitis, emphysema, influenza, and pneumonia. It has been used in small doses as a topical anesthetic for mouth or pharyngeal pain.

Physical properties about Benzonatate are: (1)ACD/LogP: 0.48; (2)# of Rule of 5 Violations: 2; (3)ACD/LogD (pH 5.5): 0.48; (4)ACD/LogD (pH 7.4): 0.48; (5)ACD/BCF (pH 5.5): 1.37; (6)ACD/BCF (pH 7.4): 1.37; (7)ACD/KOC (pH 5.5): 43.49; (8)ACD/KOC (pH 7.4): 43.51; (9)#H bond acceptors: 12; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 33; (12)Polar Surface Area: 112.61 Å²; (13)Index of Refraction: 1.495; (14)Molar Refractivity: 160.63 cm³; (15)Molar Volume: 550.6 cm³; (16)Polarizability: 63.67×10^-24cm³; (17)Surface Tension: 39.8 dyne/cm; (18)Density: 1.096 g/cm³; (19)Flash Point: 346.3 °C; (20)Enthalpy of Vaporization: 95.67 kJ/mol; (21)Boiling Point: 649 °C at 760 mmHg; (22)Vapour Pressure: 9.98E-17 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: O=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)c1ccc(NCCCC)cc1
(2)InChI: InChI=1/C30H53NO11/c1-3-4-9-31-29-7-5-28(6-8-29)30(32)42-27-26-41-25-24-40-23-22-39-21-20-38-19-18-37-17-16-36-15-14-35-13-12-34-11-10-33-2/h5-8,31H,3-4,9-27H2,1-2H3
(3)InChIKey: MAFMQEKGGFWBAB-UHFFFAOYAD
(4)Std. InChI: InChI=1S/C30H53NO11/c1-3-4-9-31-29-7-5-28(6-8-29)30(32)42-27-26-41-25-24-40-23-22-39-21-20-38-19-18-37-17-16-36-15-14-35-13-12-34-11-10-33-2/h5-8,31H,3-4,9-27H2,1-2H3
(5)Std. InChIKey: MAFMQEKGGFWBAB-UHFFFAOYSA-N

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
cat	LD50	intravenous	4mg/kg (4mg/kg)		Schweizerische Medizinische Wochenschrift. Vol. 86, Pg. 94, 1956.
dog	LD50	subcutaneous	217mg/kg (217mg/kg)		Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 54, Pg. 688, 1958.
guinea pig	LD50	intravenous	4400ug/kg (4.4mg/kg)		Arzneimittel-Forschung. Drug Research. Vol. 7, Pg. 739, 1957.
man	TDLo	oral	51mg/kg (51mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD CARDIAC: OTHER CHANGES	Journal of Toxicology, Clinical Toxicology. Vol. 36, Pg. 713, 1998.
mouse	LD50	intravenous	9mg/kg (9mg/kg)		Helvetica Physiologia et Pharmacologica Acta. Vol. 15, Pg. 55, 1957.
mouse	LD50	oral	400mg/kg (400mg/kg)		Schweizerische Medizinische Wochenschrift. Vol. 86, Pg. 94, 1956.
mouse	LD50	subcutaneous	100mg/kg (100mg/kg)		Chemical and Pharmaceutical Bulletin. Vol. 7, Pg. 372, 1959.
rabbit	LD50	intravenous	5mg/kg (5mg/kg)		Schweizerische Medizinische Wochenschrift. Vol. 86, Pg. 94, 1956.
rabbit	LD50	subcutaneous	200mg/kg (200mg/kg)		Schweizerische Medizinische Wochenschrift. Vol. 86, Pg. 94, 1956.